切换至 "中华医学电子期刊资源库"

中华乳腺病杂志(电子版) ›› 2016, Vol. 10 ›› Issue (03) : 177 -179. doi: 10.3877/cma.j.issn.1674-0807.2016.03.012

综述

多学科协作模式在乳腺癌诊治中的应用
唐振宁1, 刘奇伦1,()   
  1. 1.750004 银川,宁夏医科大学总医院肿瘤医院肿瘤外科
  • 收稿日期:2015-12-18 出版日期:2016-06-01
  • 通信作者: 刘奇伦

Multidisciplinary team for diagnosis and treatment of breast cancer

Zhenning Tang, Qilun Liu()   

  • Received:2015-12-18 Published:2016-06-01
  • Corresponding author: Qilun Liu
引用本文:

唐振宁, 刘奇伦. 多学科协作模式在乳腺癌诊治中的应用[J/OL]. 中华乳腺病杂志(电子版), 2016, 10(03): 177-179.

Zhenning Tang, Qilun Liu. Multidisciplinary team for diagnosis and treatment of breast cancer[J/OL]. Chinese Journal of Breast Disease(Electronic Edition), 2016, 10(03): 177-179.

乳腺癌目前是中国女性发病率最高的恶性肿瘤,但在中国,乳腺癌的诊治仍需进一步提高与规范。 临床多学科协作团队(MDT)是目前国际公认的主流肿瘤治疗模式,是规范乳腺癌诊治的重要手段。 笔者就目前国内外MDT 在乳腺癌诊治中的应用现状及进展进行简要综述。

[1]
Jalil R, Lamb B, Russ S, et al. The cancer multi-disciplinary team from the co-ordinators' perspective:results from a national survey in the UK[J]. BMC Health Serv Res,2012,12:457.
[2]
华长江,郝虹. 肿瘤多学科会诊的现状与展望[J]. 医学综述,2015,21(3):431-434.
[3]
Rajan S, Foreman J, Wallis MG, et al. Multidisciplinary decisions in breast cancer: does the patient receive what the team has recommended? [J]. Br J Cancer,2013,108(12):2442-2447.
[4]
Friedman EL, Chawla N, Morris PT, et al. Assessing the development of multidisciplinary care: experience of the National Cancer Institute Community Cancer Centers program[J]. J Oncol Pract, 2014,11(1):e36-e43.
[5]
Fleissig A, Jenkins V, Catt S, et al. Multidisciplinary teams in cancer care: are they effective in the UK? [J]. Lancet Oncol,2006,7(11):935-943.
[6]
徐茂,尤明春,马万兵. 多学科专家组诊疗模式在肿瘤诊疗活动中的实践[J]. 东南国防医药,2013,15(2):157-159.
[7]
Borras JM, Albreht T, Audisio R, et al. Policy statement on multidisciplinary cancer care [J]. Eur J Cancer, 2014,50 (3):475-480.
[8]
Bensenhaver J, Winchester DP. Surgical leadership and standardization of multidisciplinary breast cancer care: the evolution of the national accreditation program for breast centers[J]. Surg Oncol Clin N Am,2014,23(3):609-616.
[9]
Kesson EM, Allardice GM, George WD, et al. Effects of multidisciplinary team working on breast cancer survival: retrospective,comparative, interventional cohort study of 13 722 women[J]. BMJ,2012,344:e2718.
[10]
Eaker S, Dickman PW, Hellstrom V, et al. Regional differences in breast cancer survival despite common guidelines [ J]. Cancer Epidemiol Biomarkers Prev,2005,14(12):2914-2918.
[11]
Yip CH, Buccimazza I, Hartman M, et al. Improving outcomes in breast cancer for low and middle income countries[J]. World J Surg,2015,39(3):686-692.
[12]
Taylor C, Shewbridge A, Harris J, et al. Benefits of multidisciplinary teamwork in the management of breast cancer[J]. Breast Cancer (Dove Med Press),2013,5:79-85.
[13]
Carstensen L, Rose M, Bentzon N, et al. Knowledge and opinions on oncoplastic surgery among breast and plastic surgeons[J]. Dan Med J,2015,62(4):A5030.
[14]
Harper JL,De Costa AM,Garrett-Mayer E,et al. Incorporating patient satisfaction metrics in assessing multidisciplinary breast cancer care quality[J]. South Med J,2015,108(6):372-376.
[15]
Boughey JC, Dietz J. Providing the best care for patients with breast cancer through use of the multidisciplinary team[J]. Ann Surg Oncol,2014,21(10):3163-3165.
[16]
Saini KS, Taylor C, Ramirez AJ, et al. Role of the multidisciplinary team in breast cancer management: results from a large international survey involving 39 countries[J]. Ann Oncol,2012,23(4):853-859..
[17]
Chae BJ, Bae JS, Song BJ, et al. Multidisciplinary team approach in breast cancer: a nationwide survey in Korea[J]. J Korean Surg Soc,2012,82(6):340-346.
[18]
English R, Metcalfe C, Day J, et al. A prospective analysis of implementation of multi-disciplinary team decisions in breast cancer[J]. Breast J,2012,18(5):459-463.
[19]
Prabhakar CN, Fong KM, Peake MD, et al. The effectiveness of lung cancer MDT and the role of respiratory physicians[J]. Respirology,2015,20(6):884-888.
[20]
Taylor C, Munro AJ, Glynne-Jones R, et al. Multidisciplinary team working in cancer:what is the evidence? [J]. BMJ,2010,340:c951.
[1] 王佳佳, 詹韵韵, 姜凡, 孙碧云, 毕玉, 李如冰, 彭梅. Peyton四步教学法在超声住院医师规范化培训颈部淋巴结分区中的应用[J/OL]. 中华医学超声杂志(电子版), 2024, 21(08): 814-818.
[2] 周易, 张红梅, 尹立雪, 杨浩, 付培. 四川省超声医学质量控制指标动态变化趋势分析[J/OL]. 中华医学超声杂志(电子版), 2024, 21(07): 664-670.
[3] 王晓娜, 张宁, 宋伟, 杨明, 李丽, 薛红元. 河北省超声医学质量管理与控制现状分析[J/OL]. 中华医学超声杂志(电子版), 2024, 21(07): 675-680.
[4] 张亚庆, 黄旴宁, 许珊珊, 刘小蓝. 海南省二级与三级医院超声医学质量控制指标分析[J/OL]. 中华医学超声杂志(电子版), 2024, 21(07): 681-685.
[5] 李洋, 蔡金玉, 党晓智, 常婉英, 巨艳, 高毅, 宋宏萍. 基于深度学习的乳腺超声应变弹性图像生成模型的应用研究[J/OL]. 中华医学超声杂志(电子版), 2024, 21(06): 563-570.
[6] 河北省抗癌协会乳腺癌专业委员会护理协作组. 乳腺癌中心静脉通路护理管理专家共识[J/OL]. 中华乳腺病杂志(电子版), 2024, 18(06): 321-329.
[7] 刘晨鹭, 刘洁, 张帆, 严彩英, 陈倩, 陈双庆. 增强MRI 影像组学特征生境分析在预测乳腺癌HER-2 表达状态中的应用[J/OL]. 中华乳腺病杂志(电子版), 2024, 18(06): 339-345.
[8] 张晓宇, 殷雨来, 张银旭. 阿帕替尼联合新辅助化疗对三阴性乳腺癌的疗效及预后分析[J/OL]. 中华乳腺病杂志(电子版), 2024, 18(06): 346-352.
[9] 邱琳, 刘锦辉, 组木热提·吐尔洪, 马悦心, 冷晓玲. 超声影像组学对致密型乳腺背景中非肿块型乳腺癌的诊断价值[J/OL]. 中华乳腺病杂志(电子版), 2024, 18(06): 353-360.
[10] 高杰红, 黎平平, 齐婧, 代引海. ETFA和CD34在乳腺癌中的表达及与临床病理参数和预后的关系研究[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 64-67.
[11] 韩萌萌, 冯雪园, 马宁. 乳腺癌改良根治术后桡神经损伤1例[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 117-118.
[12] 张志兆, 王睿, 郜苹苹, 王成方, 王成, 齐晓伟. DNMT3B与乳腺癌预后的关系及其生物学机制[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 624-629.
[13] 王玲艳, 高春晖, 冯雪园, 崔鑫淼, 刘欢, 赵文明, 张金库. 循环肿瘤细胞在乳腺癌新辅助及术后辅助治疗中的应用[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 630-633.
[14] 赵林娟, 吕婕, 王文胜, 马德茂, 侯涛. 超声引导下染色剂标记切缘的梭柱型和圆柱型保乳区段切除术的效果研究[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 634-637.
[15] 陈明敏, 任菁菁. 全科医师叙事能力探讨与思考[J/OL]. 中华临床医师杂志(电子版), 2024, 18(09): 836-840.
阅读次数
全文


摘要